| Literature DB >> 35409726 |
Patrycja Proc1, Joanna Szczepanska1, Anna Herud2, Malgorzata Zubowska3, Wojciech Fendler4,5, Monika Lukomska-Szymanska6, Wojciech Mlynarski7.
Abstract
BACKGROUND: There is lack of data related to dental occlusion among children cured from cancer. The aim of our study was to compare the prevalence of malocclusion in cancer survivors and in healthy peers.Entities:
Keywords: childhood cancer survivors; dental age; malocclusion
Mesh:
Year: 2022 PMID: 35409726 PMCID: PMC8997965 DOI: 10.3390/ijerph19074045
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Diagram of inclusion and exclusion criteria for both groups.
Distribution of cancer diseases among patients.
| Cancer Type | Girls | Boys | Total |
|---|---|---|---|
| Acute leukemia | 9 | 25 | 34 (45.33%) |
| Wilms tumor | 6 | 5 | 11 (14.66%) |
| Neuroblastoma | 3 | 6 | 9 (12%) |
| Other soft tissue tumors | 2 | 7 | 9 (12%) |
| Brain tumor | 3 | 2 | 5 (6.66%) |
| Lymphoma | 0 | 4 | 4 (5.33%) |
| Hepatoblastoma | 0 | 3 | 3 (4%) |
| Total | 23 | 52 | 75 (100%) |
Distribution of dental occlusion types in cancer and control groups.
| Occlusion | Cancer | Control |
|
|---|---|---|---|
| Malocclusion | 49 (65.33%) | 99 (65.56%) | 0.9727 |
| Class I | 51 (68.00%) | 94 (62.25%) | 0.9361 |
| Class II (distocclusion) | 21 (28.00%) | 52 (34.44%) | 0.3670 |
| Class III (reversed overjet) | 6 (8.00%) | 3 (1.99%) | 0.0628 |
| Abnormal overjet | 3 (4.00%) | 5 (3.31%) | 1.0000 |
| Crossbite anterior | 10 (13.33%) | 6 (3.97%) | 0.0136 |
| Crossbite posterior | 14 (18.67%) | 7 (4.64%) | 0.0012 |
| Open bite anterior | 1 (1.33%) | 13 (8.61%) | 0.0387 |
| Open bite posterior | 2 (2.67%) | 0 | 0.1091 |
| Deep bite | 1 (1.33%) | 12 (7.95%) | 0.0651 |
| Scissors bite | 0 | 2 (1.32%) | 1.0000 |
| Crowding/rotations | 6 (8.00%) | 15 (9.93%) | 0.8195 |
| Malalignment | 14 (18.67%) | 12 (7.95%) | 0.0310 |
| Spacing | 2 (2.67%) | 0 | 0.1091 |
| Midline shift/Mandibular displacement | 3 (4.00%) | 6 (3.97%) | 1.0000 |
| Maxillary narrowing | 1 (1.33%) | 11 (7.28) | 0.0662 |
Distribution of tooth anomalies in cancer patients with different types of dental occlusion.
| Occlusion | Agenesis |
| Microdontic Teeth |
| Short Roots |
| |
|---|---|---|---|---|---|---|---|
| Malocclusion | no | 0 (0–2) | 0.2160 | 0 (0–2) | 0.7375 | 0 (0–0) | 0.6838 |
| yes | 0 (0–1) | 0 (0–2) | 0 (0–0) | ||||
| Class I | no | 0 (0–1.5) | 0.9061 | 0 (0–1.5) | 0.8482 | 0 (0–0) | 0.8479 |
| yes | 0 (0–1) | 0 (0–3) | 0 (0–0) | ||||
| Class II (distocclusion) | no | 0 (0–1) | 0.9922 | 0 (0–3) | 0.3874 | 0 (0–0) | 0.8606 |
| yes | 0 (0–1.5) | 0 (0–1) | 0 (0–0) | ||||
| Class III | no | 0 (0–2) | 0.2434 | 0 (0–2) | 1.0000 | 0 (0–0) | 0.5806 |
| yes | 0 (0–0) | 0 (0–4) | 0 (0–0) | ||||
| Abnormal overjet (incisors protrusion) | no | 0 (0-1) | 0.9527 | 0 (0–2) | 0.3433 | 0 (0–0) | 0.2241 |
| yes | 0 (0–3) | 2 (0–4) | 0 (0–2) | ||||
| Crossbite anterior | no | 0 (0–2) | 0.9093 | 0 (0–2) | 0.7432 | 0 (0–0) | 0.2143 |
| yes | 0 (0–1) | 0 (0–3.5) | 0 (0–4) | ||||
| Crossbite posterior | no | 0 (0–2) | 0.6998 | 0 (0–2) | 1.0000 | 0 (0–0) | 0.0161 |
| yes | 0 (0–1) | 0 (0–1) | 0 (0–2) | ||||
| Open bite posterior | no | 0 (0–1.5) | 0.3490 | 0 (0–2) | 0.6288 | 0 (0–0) | 0.6374 |
| yes | 0 (0–0) | 2 (0–4) | 0 (0–0) | ||||
| Crowding/rotations | no | 0 (0–2) | 0.1725 | 0 (0–2) | 0.7657 | 0 (0–0) | 0.5152 |
| yes | 0 (0–0) | 0.5 (0–2.5) | 0 (0–0) | ||||
| Malalignment | no | 0 (0–1.5) | 0.5333 | 0 (0–2) | 0.3360 | 0 (0–0) | 0.9388 |
| yes | 0 (0–0) | 1 (0–4) | 0 (0–0) | ||||
| Midline shift/Mandibular displacement | no | 0 (0–1) | 0.0127 | 0 (0–2) | 0.7617 | 0 (0–0) | 0.5505 |
| yes | 3 (1–7) | 1 (0–1) | 0 (0–0) |
Data with no evidence were excluded from the statistical analysis.
Comparison of dental age (DA-CA) among cancer patients with different types of dental occlusion.
| Crossbite | Delta DA-CA |
| |
|---|---|---|---|
| Class I | Yes | 0.53 (0.13–1.27) | 0.2611 |
| No | 1.02 (0.17–2.13) | ||
| Class II (distocclusion) | Yes | 0.92 (0.13–1.65) | 0.9936 |
| No | 0.53 (0.33–1.75) | ||
| Class III (reversed overjet) | Yes | 0.92 (0.17–1.75) | 0.4059 |
| No | 0.28 (−1.27–1.83) | ||
| Abnormal overjet (incisor protrusion) | Yes | 0.92 (0.13–1.75) | 0.9877 |
| No | 0.53 (0.33–2.12) | ||
| Crossbite anterior | Yes | 1.60 (0.53–2.67) | 0.2599 |
| No | 0.84 (0.15–1.46) | ||
| Crossbite posterior | Yes | 1.75 (1.12–3.17) | 0.0235 |
| No | 0.80 (0.13–1.27) | ||
| Crowding/rotations | Yes | 0.93 (0.22–1.83) | 0.4124 |
| No | 0.53 (0.08–1.02) | ||
| Malalignment | Yes | 1.07 (0.31–1.98) | 0.0226 |
| No | 0.12 (−0.23–0.73) | ||
| Spacing | Yes | 0.91 (0.15–1.7) | 0.6671 |
| No | 1.7 (0.22–3.18) |
DA—dental age, CA—chronological age.
Figure 2(a) Girl (cancer patient 1), aged 114 months, diagnosed with rhabdomyosarcoma (RMS) at the age of 57 months, treated for 36 months with CWS06-CEVAIE and TC protocols, with disease relapse, with posterior crossbite and persistent tooth 62, malformed roots and disturbed eruption of tooth 45; (b) Boy (cancer patient 2), aged 119 months, diagnosed with brain tumor at the age of 80 months, treated for 19 months with CZD II protocol and RTX of head, with anterior crossbite, spacing, and malformed roots.
Cancer-related variables in patients with different types of malocclusion.
| Mesio-Distal Changes | Transversal Changes | Vertical Changes | Tooth Disturbances | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yes | No |
| Yes | No |
| Yes | No |
| Yes | No |
| |
| Median (25–75) percentile values) | Median (25–75) percentile values) | Median (25–75) percentile values) | Median (25–75) percentile values) | Median (25–75) percentile values) | Median (25–75) percentile values) | Median (25–75) percentile values) | Median (25–75) percentile values) | |||||
| Age at the beginning | 33 (22–62) | 33 (18.5–48.5) | 0.4655 | 29.5 (17–52) | 33 (22–54) | 0.5450 | 31 (1–79) | 33 (20–53) | 0.7868 | 57 (28–80) | 30.5 (17–39) | 0.0198 |
| Length of disease | 13 (5–25) | 21 (10–26) | 0.2866 | 21.5 (6–26) | 20 (6–25) | 0.4839 | 24 (5–28) | 20 (6–25) | 0.7043 | 20 (13–26) | 20.5 (6–25) | 0.8342 |
| RTX of head (yes) | 3/23 * | 8/52 | 1.00 | 4/22 | 7/53 | 0.7213 | 0/3 | 11/72 | 1.00 | 2/17 | 9/58 | 1.00 |
| Relapse (yes) | 2/23 | 6/52 | 1.00 | 4/22 | 4/52 | 0.2271 | 0/3 | 8/72 | 1.00 | 2/16 | 6/58 | 1.00 |
| TBI (yes) | 0/23 | 1/52 | 1.00 | 0/22 | 1/53 | 1.00 | 0/3 | 1/72 | 1.00 | 0/17 | 1/58 | 1.00 |
* Patients with RTX and malocclusion vs. patients with RTX only, RTX—radiotherapy of head or neck; TBI—total body irradiation.